Regulating forensic genetic genealogy
By Natalie Ram, Erin E. Murphy, and Sonia M. Suter,
Science
| 09. 24. 2021
In May 2021, Maryland enacted the first law in the United States—and in the world—that comprehensively regulates law enforcement’s use of consumer genetic data to investigate crimes (1). Until now, the primary restraint on law enforcement has come from consumer genetics platforms themselves, with some declining to cooperate, some covertly cooperating, and a handful working openly with criminal investigators. Courts have largely taken a hands-off approach, and one of the only efforts at oversight emerged from the US Department of Justice (DOJ), which issued an “interim” policy in November 2019. By contrast, Maryland’s new law—adopted with near-unanimous, bipartisan support—engaged a broad array of stakeholders and was adopted by elected officials after a transparent and open legislative process. Its success provides a roadmap for regulating genetic genealogy in a way that balances privacy and public safety, and its terms include six critical features that others should model moving forward.
Solving Crimes, Provoking Alarm
The technology at issue in the Maryland law came to the public’s attention with the high-profile arrest of Joseph James DeAngelo Jr. as the Golden State...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...